Bildkälla: Stockfoto

BioInvent: New Clinical Trial Collaboration and Supply Agreement with MSD - Redeye

Redeye is optimistic about the new agreement with MSD/Merck to provide Keytruda for the combination part of the phase I/IIa study of BI-1910.

Redeye is optimistic about the new agreement with MSD/Merck to provide Keytruda for the combination part of the phase I/IIa study of BI-1910.
Börsvärldens nyhetsbrev
ANNONSER